- Report
- September 2023
- 202 Pages
Global
From €4065EUR$4,450USD£3,466GBP
- Report
- January 2023
- 164 Pages
Global
From €4065EUR$4,450USD£3,466GBP
- Report
- June 2022
- 165 Pages
Global
From €4065EUR$4,450USD£3,466GBP
- Report
- March 2022
- 155 Pages
Global
From €4065EUR$4,450USD£3,466GBP
- Report
- February 2024
- 46 Pages
Asia Pacific
From €320EUR$350USD£273GBP
- Report
- February 2024
- 53 Pages
Global
From €320EUR$350USD£273GBP
- Report
- February 2024
- 49 Pages
Europe
From €320EUR$350USD£273GBP
- Report
- February 2024
- 48 Pages
Germany
From €320EUR$350USD£273GBP
- Report
- February 2024
- 46 Pages
China
From €320EUR$350USD£273GBP
- Report
- November 2023
- 176 Pages
Global
From €4065EUR$4,450USD£3,466GBP
- Report
- January 2023
- 190 Pages
Asia Pacific
From €3152EUR$3,450USD£2,687GBP
- Report
- October 2022
- 267 Pages
Global
From €4065EUR$4,450USD£3,466GBP
- Report
- April 2019
- 99 Pages
India
From €3152EUR$3,450USD£2,687GBP
- Report
- February 2024
- 116 Pages
Global
From €4111EUR$4,500USD£3,505GBP
- Report
- January 2024
- 118 Pages
Global
From €4111EUR$4,500USD£3,505GBP
- Report
- January 2024
- 113 Pages
Global
From €4111EUR$4,500USD£3,505GBP
- Report
- December 2023
- 115 Pages
Global
From €4111EUR$4,500USD£3,505GBP
- Report
- October 2023
- 114 Pages
Global
From €4111EUR$4,500USD£3,505GBP
- Report
- July 2023
- 119 Pages
Global
From €4111EUR$4,500USD£3,505GBP
- Report
- July 2023
- 113 Pages
Global
From €4111EUR$4,500USD£3,505GBP

The biotechnology Research and Development (R&D) market is a rapidly growing sector of the biotechnology industry. It involves the development of new products and technologies, as well as the improvement of existing ones. Companies in this market are typically focused on the development of new drugs, diagnostics, medical devices, and other biotechnological products. They also conduct research into the biological processes and mechanisms that underlie diseases and other medical conditions.
R&D in biotechnology is often conducted in collaboration with universities, government agencies, and other organizations. This collaboration allows for the sharing of resources and expertise, and helps to ensure that the latest technologies and discoveries are being used.
Some of the major companies in the biotechnology R&D market include Amgen, Biogen, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. These companies are involved in the development of new drugs, diagnostics, and medical devices, as well as the improvement of existing ones. They also conduct research into the biological processes and mechanisms that underlie diseases and other medical conditions. Show Less Read more